This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Rabies Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (ERIG, HRIG); Application (Category II Exposure, Category III Exposure) and Geography
Rabies is a zoonotic viral disease caused due to animal bites. The disease is mainly transmitted from domestic and wild animals such as bats, foxes, raccoons, cats, or dogs and infects humans upon contacting infected animal saliva. Its incubation period is of one to three months. Several symptoms are shown in individuals suffering from rabies, such as fever and pain or burning sensation (paraesthesia) at the wound site. One of the approved and effective methods against rabies is rabies immunoglobulin, i.e., a medication made up of antibodies against the rabies virus to prevent rabies.
MARKET SCOPE
The "Global Rabies Immunoglobulin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the rabies immunoglobulin market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading rabies immunoglobulin market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
Based on type, the global rabies immunoglobulin market is segmented into ERIG and HRIG.
Based on application, the market is segmented into category II exposure and category III exposure.
MARKET DYNAMICS Drivers:
The rising geriatrics population, increasing prevalence of target diseases, and rising cases of rabies drive the rabies immunoglobulin market growth.
Growing development of effective human rabies immunoglobulin and rising preference for point-of-care testing boost market growth.
Growing government initiatives fuel market growth.
Restraints:
Absence of a predefined regulatory framework.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The rabies immunoglobulin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the rabies immunoglobulin market in these regions.
IMPACT OF COVID-19 ON RABIES IMMUNOGLOBULIN MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 pandemic had affected the growth of the market. As per the data of the CDC, 2020, several animals, including cats, dogs, and a few other types of animals, were at potential risk of acquiring the virus. Therefore, a study was conducted that showed the rapid development of a novel, highly efficient, and safe COVID-19 vaccine via a rabies virus-based vector which proved to be an efficient vaccine against several emerging infectious diseases. Hence, the market growth was surged due to these developments during the pandemic.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the rabies immunoglobulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from rabies immunoglobulin market are anticipated to have lucrative growth opportunities in the future with the rising demand for rabies immunoglobulin in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the rabies immunoglobulin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Grifols USA
CSL Behring
Sichuan Yuanda Shuyang
Sanofi
Shanghai RAAS
KEDRAB
Bharat Serum
Kamada
Vins Bioproducts Limited.
Bio Products Laboratory Limited
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rabies Immunoglobulin Market - By Type
1.3.2 Rabies Immunoglobulin Market - By Application
1.3.3 Rabies Immunoglobulin Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RABIES IMMUNOGLOBULIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
6. RABIES IMMUNOGLOBULIN MARKET - GLOBAL MARKET ANALYSIS
6.1. RABIES IMMUNOGLOBULIN - GLOBAL MARKET OVERVIEW
6.2. RABIES IMMUNOGLOBULIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. RABIES IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ERIG
7.3.1. Overview
7.3.2. ERIG Market Forecast and Analysis
7.4. HRIG
7.4.1. Overview
7.4.2. HRIG Market Forecast and Analysis
8. RABIES IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CATEGORY II EXPOSURE
8.3.1. Overview
8.3.2. Category II Exposure Market Forecast and Analysis
8.4. CATEGORY III EXPOSURE
8.4.1. Overview
8.4.2. Category III Exposure Market Forecast and Analysis
9. RABIES IMMUNOGLOBULIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Rabies Immunoglobulin Market Overview
9.1.2 North America Rabies Immunoglobulin Market Forecasts and Analysis
9.1.3 North America Rabies Immunoglobulin Market Forecasts and Analysis - By Type
9.1.4 North America Rabies Immunoglobulin Market Forecasts and Analysis - By Application
9.1.5 North America Rabies Immunoglobulin Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Rabies Immunoglobulin Market
9.1.5.1.1 Canada Rabies Immunoglobulin Market by Type
9.1.5.1.2 Canada Rabies Immunoglobulin Market by Application
9.1.5.2 Mexico Rabies Immunoglobulin Market
9.1.5.2.1 Mexico Rabies Immunoglobulin Market by Type
9.1.5.2.2 Mexico Rabies Immunoglobulin Market by Application
9.1.5.3 US Rabies Immunoglobulin Market
9.1.5.3.1 US Rabies Immunoglobulin Market by Type
9.1.5.3.2 US Rabies Immunoglobulin Market by Application
9.2. EUROPE
9.2.1 Europe Rabies Immunoglobulin Market Overview
9.2.2 Europe Rabies Immunoglobulin Market Forecasts and Analysis
9.2.3 Europe Rabies Immunoglobulin Market Forecasts and Analysis - By Type
9.2.4 Europe Rabies Immunoglobulin Market Forecasts and Analysis - By Application
9.2.5 Europe Rabies Immunoglobulin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Rabies Immunoglobulin Market
9.2.5.1.1 Germany Rabies Immunoglobulin Market by Type
9.2.5.1.2 Germany Rabies Immunoglobulin Market by Application
9.2.5.2 France Rabies Immunoglobulin Market
9.2.5.2.1 France Rabies Immunoglobulin Market by Type
9.2.5.2.2 France Rabies Immunoglobulin Market by Application
9.2.5.3 Italy Rabies Immunoglobulin Market
9.2.5.3.1 Italy Rabies Immunoglobulin Market by Type
9.2.5.3.2 Italy Rabies Immunoglobulin Market by Application
9.2.5.4 Spain Rabies Immunoglobulin Market
9.2.5.4.1 Spain Rabies Immunoglobulin Market by Type
9.2.5.4.2 Spain Rabies Immunoglobulin Market by Application
9.2.5.5 United Kingdom Rabies Immunoglobulin Market
9.2.5.5.1 United Kingdom Rabies Immunoglobulin Market by Type
9.2.5.5.2 United Kingdom Rabies Immunoglobulin Market by Application
9.2.5.6 Rest of Europe Rabies Immunoglobulin Market
9.2.5.6.1 Rest of Europe Rabies Immunoglobulin Market by Type
9.2.5.6.2 Rest of Europe Rabies Immunoglobulin Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Rabies Immunoglobulin Market Overview
9.3.2 Asia-Pacific Rabies Immunoglobulin Market Forecasts and Analysis
9.3.3 Asia-Pacific Rabies Immunoglobulin Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Rabies Immunoglobulin Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Rabies Immunoglobulin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Rabies Immunoglobulin Market
9.3.5.1.1 Australia Rabies Immunoglobulin Market by Type
9.3.5.1.2 Australia Rabies Immunoglobulin Market by Application
9.3.5.2 China Rabies Immunoglobulin Market
9.3.5.2.1 China Rabies Immunoglobulin Market by Type
9.3.5.2.2 China Rabies Immunoglobulin Market by Application
9.3.5.3 India Rabies Immunoglobulin Market
9.3.5.3.1 India Rabies Immunoglobulin Market by Type
9.3.5.3.2 India Rabies Immunoglobulin Market by Application
9.3.5.4 Japan Rabies Immunoglobulin Market
9.3.5.4.1 Japan Rabies Immunoglobulin Market by Type
9.3.5.4.2 Japan Rabies Immunoglobulin Market by Application
9.3.5.5 South Korea Rabies Immunoglobulin Market
9.3.5.5.1 South Korea Rabies Immunoglobulin Market by Type
9.3.5.5.2 South Korea Rabies Immunoglobulin Market by Application
9.3.5.6 Rest of Asia-Pacific Rabies Immunoglobulin Market
9.3.5.6.1 Rest of Asia-Pacific Rabies Immunoglobulin Market by Type
9.3.5.6.2 Rest of Asia-Pacific Rabies Immunoglobulin Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Rabies Immunoglobulin Market Overview
9.4.2 Middle East and Africa Rabies Immunoglobulin Market Forecasts and Analysis
9.4.3 Middle East and Africa Rabies Immunoglobulin Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Rabies Immunoglobulin Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Rabies Immunoglobulin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Rabies Immunoglobulin Market
9.4.5.1.1 South Africa Rabies Immunoglobulin Market by Type
9.4.5.1.2 South Africa Rabies Immunoglobulin Market by Application
9.4.5.2 Saudi Arabia Rabies Immunoglobulin Market
9.4.5.2.1 Saudi Arabia Rabies Immunoglobulin Market by Type
9.4.5.2.2 Saudi Arabia Rabies Immunoglobulin Market by Application
9.4.5.3 U.A.E Rabies Immunoglobulin Market
9.4.5.3.1 U.A.E Rabies Immunoglobulin Market by Type
9.4.5.3.2 U.A.E Rabies Immunoglobulin Market by Application
9.4.5.4 Rest of Middle East and Africa Rabies Immunoglobulin Market
9.4.5.4.1 Rest of Middle East and Africa Rabies Immunoglobulin Market by Type
9.4.5.4.2 Rest of Middle East and Africa Rabies Immunoglobulin Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Rabies Immunoglobulin Market Overview
9.5.2 South and Central America Rabies Immunoglobulin Market Forecasts and Analysis
9.5.3 South and Central America Rabies Immunoglobulin Market Forecasts and Analysis - By Type
9.5.4 South and Central America Rabies Immunoglobulin Market Forecasts and Analysis - By Application
9.5.5 South and Central America Rabies Immunoglobulin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Rabies Immunoglobulin Market
9.5.5.1.1 Brazil Rabies Immunoglobulin Market by Type
9.5.5.1.2 Brazil Rabies Immunoglobulin Market by Application
9.5.5.2 Argentina Rabies Immunoglobulin Market
9.5.5.2.1 Argentina Rabies Immunoglobulin Market by Type
9.5.5.2.2 Argentina Rabies Immunoglobulin Market by Application
9.5.5.3 Rest of South and Central America Rabies Immunoglobulin Market
9.5.5.3.1 Rest of South and Central America Rabies Immunoglobulin Market by Type
9.5.5.3.2 Rest of South and Central America Rabies Immunoglobulin Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. RABIES IMMUNOGLOBULIN MARKET, KEY COMPANY PROFILES
11.1. GRIFOLS USA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CSL BEHRING
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SICHUAN YUANDA SHUYANG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. SHANGHAI RAAS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. KEDRAB
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BHARAT SERUM
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. KAMADA
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. VINS BIOPRODUCTS LIMITED.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BIO PRODUCTS LABORATORY LIMITED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
